热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD8a Antibody
产品名称：
PE/Cyanine7 anti-mouse CD8a Antibody
产品类别：
抗体
产品编号：
100721
产品应用：
100721
[价格]
规格 价格 库存
25µg ￥ 816 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  30. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed
  2. Calabrese DR, et al. 2020. J Clin Invest. . PubMed
  3. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  4. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  7. Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  8. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  9. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  10. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  11. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  12. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  13. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  14. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  15. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  16. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  17. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  18. Baram T, et al. 2021. Cells. 10:. PubMed
  19. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  20. Luo R, et al. 2021. Theranostics. 11:117. PubMed
  21. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  22. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  23. Ma F, et al. 2020. Cell Death Dis. 1.172222222. PubMed
  24. Leier A, et al. 2022. Mol Ther Nucleic Acids. 28:261. PubMed
  25. Andreas N, et al. 2021. Arthritis Res Ther. 23:222. PubMed
  26. Alotaibi F, et al. 2021. Front Immunol. 11:584937. PubMed
  27. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  28. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  29. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  30. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  31. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  32. Saito S, et al. 2020. Nutrients. 12:. PubMed
  33. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  34. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  35. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  36. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  37. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  38. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  39. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  40. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  41. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  42. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  43. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  44. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  45. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  46. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  47. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  48. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  49. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  50. Guo HF, et al. 2021. Commun Biol. 4:482. PubMed
  51. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  52. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  53. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  54. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  55. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  56. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  57. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  58. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  59. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  60. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  61. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  62. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  63. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  64. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  65. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  66. Amor C, et al. 2020. Nature. 583:127. PubMed
  67. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  68. Szafran BN, et al. 2021. Chemical Research in Toxicology. 34(6):1556-1571. PubMed
  69. Li J, et al. 2020. Cancer Discov. . PubMed
  70. Wei SC, et al. 2020. Cancer Discov. . PubMed
  71. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  72. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  73. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  74. Daniel CJ, et al. 2022. Mol Cancer Res. 20:1151. PubMed
  75. Sodji QH, et al. 2022. Cancer Res Commun. 2:725. PubMed
  76. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  77. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  78. Li J, et al. 2020. Cancer Immunol Res. 0.529166667. PubMed
  79. K?chl R, et al. 2020. Elife. 9:00. PubMed
  80. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  81. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  82. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  83. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  84. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  85. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  86. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  87. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  88. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  89. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  90. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  91. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  92. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  93. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  94. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  95. Li J, et al. 2018. Immunity. 49:178. PubMed
  96. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  97. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  98. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  99. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  100. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  101. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  102. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  103. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  104. Tan X, et al. 2021. Sci Adv. 7: . PubMed
  105. Sapra L, et al. 2021. Sci Rep. 11:1807. PubMed
  106. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  107. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  108. Yang Y, et al. 2022. Elife. 11:. PubMed
  109. Kim S, et al. 2021. Elife. 10:. PubMed
  110. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  111. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  112. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  113. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  114. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  115. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  116. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  117. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  118. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  119. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  120. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  121. Lang V, et al. 2021. Elife. 10:. PubMed
  122. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  123. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  124. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  125. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  126. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  127. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  128. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  129. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  130. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  131. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  132. Hsu M, et al. 2022. Nat Immunol. 23:581. PubMed
  133. Sakamoto K, et al. 2021. Immunity. 54:2321. PubMed
  134. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
  135. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  136. Niderla-Bielinska J, et al. 2021. Int J Mol Sci. :22. PubMed
  137. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  138. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  139. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  140. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  141. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  142. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  143. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  144. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  145. Bhatt D, et al. 2021. J Exp Med. 218:. PubMed
  146. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  147. Sch?nberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  148. Kojima H, et al. 2021. Scand J Immunol. 93:e13020. PubMed
  149. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  150. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
  151. Ligon MM, et al. 2020. Mucosal Immunol. 1.172222222. PubMed
  152. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  153. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  154. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  155. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  156. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  157. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  158. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
  159. Abdelsamed HA, et al. 2020. Nat Immunol. 1.276388889. PubMed
  160. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  161. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  162. Silva DA, et al. 2019. Nature. 565:186. PubMed
  163. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  164. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  165. Rouse MD, et al. 2020. Front Microbiol. 11:414. PubMed
  166. Lopes N, et al. 2022. Elife. 11:. PubMed
  167. Tang S, et al. 2022. Virol J. 19:32. PubMed
  168. Pantelidou C, et al. 2022. NPJ Breast Cancer. 8:102. PubMed
  169. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  170. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  171. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  172. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  173. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  174. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  175. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  176. Wang X, et al. 2022. Elife. 11:. PubMed
  177. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  178. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  179. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  180. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  181. Siolas D, et al. 2021. Cell Reports. 36(8):109578. PubMed
  182. Sheng J, et al. 2021. eLife. 10:00. PubMed
  183. Mykk?nen O, et al. 2014. PLoS One. 9:114790. PubMed
  184. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  185. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  186. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  187. Goubet AG, et al. 2021. Cell Death Differ. 28:2276. PubMed
  188. Petty AJ, et al. 2021. JCI Insight. 6:. PubMed
  189. Goc J, et al. 2021. Cell. :. PubMed
  190. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  191. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  192. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  193. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  194. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  195. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  196. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  197. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  198. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  199. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  200. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  201. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  202. Yá?ez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  203. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  204. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID
AB_312760 (BioLegend Cat. No. 100721) AB_312761 (BioLegend Cat. No. 100722)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线